A vial labeled TB-500 is only as useful to a research protocol as the analytical data behind it. Because the peptide is defined by a specific 43-residue amino-acid sequence, verifying that a given lot actually matches that sequence — and contains little else — is the entire basis of meaningful purity testing. Skipping this step doesn't just risk wasted material; it risks building an entire dataset on a sample that was never what the label claimed.
Reversed-phase HPLC
High-performance liquid chromatography separates a peptide sample by hydrophobicity, resolving the intended TB-500 sequence from truncated fragments, deletion sequences, and other synthesis byproducts that can arise during solid-phase synthesis. Purity is then reported as the target peak's share of total peak area — background on how to interpret that figure is at understanding HPLC purity analysis.
Confirming identity with mass spectrometry
HPLC purity alone does not confirm that the dominant peak is actually TB-500 rather than a similarly hydrophobic contaminant, which is why mass spectrometry is run alongside it. Measuring the peptide's mass and comparing it against the expected value for the full 43-residue TB-500 sequence gives an independent confirmation of identity that HPLC retention time alone cannot provide, since two different peptides can occasionally elute at similar times.
Why both tests matter for actin-binding research
TB-500 research typically depends on subtle, concentration-sensitive cellular responses tied to actin dynamics, which makes it especially vulnerable to confounding from unverified material — a sample contaminated with unrelated peptide fragments or synthesis byproducts can produce migration or angiogenesis assay results that have nothing to do with the compound actually being studied. Because the effect sizes researchers look for in these assays are often modest, even a small fraction of contaminating peptide can meaningfully shift an outcome, which is why purity thresholds in this space tend to be set conservatively rather than treated as a formality.
Documentation researchers should expect
Reputable suppliers issue a lot-specific certificate of analysis for every batch of TB-500, ideally corroborated by independent third-party lab results rather than in-house claims alone. Documented material is supplied as part of the BPC-157 + TB-500 research stack.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.